Business, News Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis' Biosimilar to Lucentis (Ranibizumab), Gains European Approval by Business Wire • 2025/12/02 • 0 Comments INCHEON, Korea--(BUSINESS WIRE)-- #amd--Samsung Bioepis' Byooviz PFS gains European approval.